Risks of Proton Pump Inhibitors in Patients with Cirrhosis: Please Peruse the Indications

被引：1
|
作者：
Low, En Xian Sarah [1 ]
Wang, Yen-Po [1 ,3 ]
Lu, Ching-Liang [1 ,2 ,3 ]
机构：
[1] Taipei Vet Gen Hosp, Endoscopy Ctr Diag & Treatment, Dept Med, Taipei, Taiwan
[2] Natl Yang Ming Chiao Tung Univ, Inst Brain Sci, Taipei, Taiwan
[3] Natl Yang Ming Chiao Tung Univ, Fac Med, Taipei, Taiwan
来源：
DIGESTIVE DISEASES AND SCIENCES | 2024年 / 69卷 / 01期
关键词：
Cirrhosis; Proton pump inhibitors; Hepatocellular carcinoma; Hepatic decompensation; Spontaneous bacterial peritonitis;
D O I：
10.1007/s10620-023-08153-3
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
The use of proton pump inhibitor (PPI) in cirrhotic patients can be associated with increased risks of long-term mortality, decompensation, hepatic encephalopathy, spontaneous bacterial peritonitis, and infection, but not with short-term mortality. Ensure clear indications at lowest effective dose of is mandatory for the use of PPI among cirrhotic patients.
引用
收藏
页码：7 / 9
页数：3
相关论文
共 50 条
  • [1] Risks of Proton Pump Inhibitors in Patients with Cirrhosis: Please Peruse the Indications
    En Xian Sarah Low
    Yen-Po Wang
    Ching-Liang Lu
    Digestive Diseases and Sciences, 2024, 69 : 7 - 9
  • [2] Risks of Proton Pump Inhibitors for Patients With Cirrhosis: The Controversy Remains
    de Mattos, Angelo Zambam
    da Silva Miozzo, Suelen Aparecida
    Tovo, Cristiane Valle
    de Mattos, Angelo Alves
    HEPATOLOGY, 2017, 66 (01) : 295 - 296
  • [3] The Indications, Applications, and Risks of Proton Pump Inhibitors
    Guntinas-Lichius, Orlando
    DEUTSCHES ARZTEBLATT INTERNATIONAL, 2017, 114 (06): : 101 - 101
  • [4] The Indications, Applications, and Risks of Proton Pump Inhibitors
    Moessner, Joachim
    DEUTSCHES ARZTEBLATT INTERNATIONAL, 2016, 113 (27-28): : 477 - +
  • [5] Risks of Proton Pump Inhibitors for Patients With Cirrhosis: The Controversy Remains REPLY
    Dam, Gitte
    Vilstrup, Hendrik
    Watson, Hugh
    Jepsen, Peter
    HEPATOLOGY, 2017, 66 (01) : 296 - 296
  • [6] Indications for proton pump inhibitors
    Faure, C
    ARCHIVES DE PEDIATRIE, 2004, 11 (06): : 674 - 676
  • [7] Safe use of proton pump inhibitors in patients with cirrhosis
    Weersink, Rianne A.
    Bouma, Margriet
    Burger, DavidM.
    Drenth, Joost P. H.
    Harkes-Idzinga, S. Froukje
    Hunfeld, Nicole G. M.
    Metselaar, Herold J.
    Monster-Simons, Margje H.
    van Putten, Sandra A. W.
    Taxis, Katja
    Borgsteede, Sander D.
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2018, 84 (08) : 1806 - 1820
  • [8] Editorial: proton pump inhibitors in cirrhosis
    Sutherland, D.
    Stanley, A. J.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2015, 41 (06) : 592 - 592
  • [9] Proton Pump Inhibitors in Patients with Cirrhosis: Pharmacokinetics, Benefits and Drawbacks
    Gasser El-Azab
    Current Gastroenterology Reports, 2024, 26 (12) : 323 - 334
  • [10] The Beauty and Sorrow of Using Proton Pump Inhibitors in Patients With Cirrhosis
    Lo, Gin-Ho
    GASTROENTEROLOGY, 2022, 163 (06) : 1717 - 1718
12345